EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 409 filers reported holding EXELIXIS INC in Q2 2024. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $760,924 | +1.2% | 33,864 | +6.9% | 0.01% | +14.3% |
Q1 2024 | $751,577 | -11.9% | 31,672 | -10.9% | 0.01% | -22.2% |
Q4 2023 | $853,156 | +5.7% | 35,563 | -3.7% | 0.01% | 0.0% |
Q3 2023 | $807,270 | +116.4% | 36,946 | +89.3% | 0.01% | +125.0% |
Q2 2023 | $373,046 | – | 19,521 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,001,073 | $320,572,000 | 64.48% |
Sargent Investment Group, LLC | 432,125 | $9,235,000 | 4.22% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 443,534 | $9,483,000 | 3.52% |
Bellevue Group AG | 3,878,800 | $82,890,000 | 1.42% |
CAPITAL MANAGEMENT CORP /VA | 237,855 | $5,083,000 | 1.40% |
Orbimed Advisors | 3,912,900 | $83,619,000 | 1.30% |
Portolan Capital Management | 540,590 | $11,552,000 | 1.24% |
TEALWOOD ASSET MANAGEMENT INC | 139,347 | $2,978,000 | 1.21% |
Signition LP | 84,120 | $1,798,000,000 | 1.18% |
Penn Capital Management Company, LLC | 529,630 | $11,318,000 | 1.12% |